by creative | Jul 19, 2022 | News
KUALA LUMPUR: Ace-Market bound UMediC Group Bhd’s public portion of its initial public offering (IPO) has been oversubscribed by 46.81 times. The medical device manufacturer, in a statement, said a total of 7,888 applications for 893.92 million IPO shares from the...
by creative | Jul 7, 2022 | News
(From left) UMediC Group Bhd (UMC) non-independent non-executive director Lau Chee Kheong and non-independent non-executive chairman Datuk Ng Chai Eng, Affin Hwang Investment Bank Bhd chairman and independent non-executive director Tunku Afwida Tunku A Malek, as well...
by creative | Jun 3, 2022 | News
UMEDIC GROUP BHD (UMC), which is seeking a listing on Bursa Malaysia, today signed an underwriting agreement with Affin Hwang Investment Bank Bhd (AHIBB), its principal adviser, sponsor, sole placement agent and sole underwriter. UMC’s initial public offering involves...
by creative | Jun 3, 2022 | News
UMediC Group Berhad has appointed Affin Hwang Investment Bank Berhad as its Principal Adviser, Sponsor, Sole Placement Agent, and Sole Underwriter for the group’s initial public offering on the ACE Market of Bursa Malaysia Securities. The group’s IPO will involve the...
by creative | Jun 3, 2022 | News
KUALA LUMPUR 3 Jun – UMediC Group Bhd. (UMC) menandatangani perjanjian taja jamin dengan Affin Hwang Investment Bank Bhd. (AHIBB) bagi tawaran awam permulaan (IPO) dan penyenaraiannya di Pasaran ACE Bursa Malaysia. AHIBB merupakan penasihat utama, penaja, ejen...
